How oncRNA Technology Could Revolutionize Cancer Diagnostics
Exai Bio combines novel oncRNA technology with AI to develop next-generation liquid biopsy tests that will aid in the detection of cancer.
Read MorePosted by Chris Wolski | Sep 2, 2022 | Cancer, Molecular Diagnostics |
Exai Bio combines novel oncRNA technology with AI to develop next-generation liquid biopsy tests that will aid in the detection of cancer.
Read MorePosted by Andy Lundin | Aug 19, 2022 | Lung Cancer |
A new collaborative project has successfully demonstrated a superior ability to detect circulating tumor DNA (ctDNA) from saliva.
Read MorePosted by Andy Lundin | Aug 1, 2022 | Cancer |
The Alliance for Clinical Trials in Oncology announced a new study that aims to assess the utility of early cancer detection blood tests.
Read MorePosted by Andy Lundin | Jul 20, 2022 | Cancer |
A key genetic mutation that occurs early on in cancer alters RNA “dark matter” and causes the release of RNA biomarkers for cancer detection.
Read MorePosted by Andy Lundin | Jul 18, 2022 | Cancer |
A research lab reported using chaperonin as a new marker for cancer cells in blood that provides a clearer indication of spreading cancer.
Read More